Plaquenil® (hydroxychloroquine) – New warnings
January 27, 2017 – The FDA approved new updates to the Warnings section of the Plaquenil (hydroxychloroquine) drug label regarding cardiac effects, including cardiomyopathy and QT prolongation, and hypoglycemia.
Download PDF
